• EDMONTON, AB – Strengthening international partnerships, GlycoNet and Spain-based CIC bioGUNE have signed a Memorandum of Understanding (MOU) to deepen collaboration in glycomics—the study of complex sugars that coat our cells and play vital roles in biology, from infection to immunity.

Under this new agreement, GlycoNet and CIC bioGUNE will jointly explore and support co-funded research projects of shared interest; facilitate exchange of trainees and researchers; and share infrastructure, scientific platforms, and data to advance glycomics for mutual benefit. Through this partnership, GlycoNet and CIC bioGUNE aim to strengthen the global impact of glycomics, driving innovations in health and biotechnology to benefit communities worldwide.

“GlycoNet has long recognized that global challenges demand global solutions. This collaboration with CIC bioGUNE is part of our strategy for building transatlantic partnerships, enabling us to pool expertise, advance health and biotech innovations, and create new training opportunities for the next generation of glycoscientists.” – Dr. Elizabeth Nanak, CEO, GlycoNet

“At CIC bioGUNE, we are deeply committed to advancing the frontiers of precision medicine. Glycoscience stands as one of the most promising areas of discovery, and our collaboration with GlycoNet represents a unique opportunity to connect the Basque, Spanish, European, and Canadian research ecosystems—fostering synergies that will accelerate innovation in this field.” – Dr. Jesús Jiménez-Barbero, Scientific Director, CIC bioGUNE

About GlycoNet
Led out of the University of Alberta, GlycoNet is a pan-Canadian research network consisting of 210+ researchers in 37 institutions across the country and has funded over 180 projects. GlycoNet investigators use the study of carbohydrates (sugars) in living cells to find solutions to unmet health needs through the development of tools, drugs, vaccines and diagnostics. Taking a One-Health approach that considers the connections among human, animal and environmental health, GlycoNet is advancing research, innovation and training in glycomics to improve quality of life for Canadians. Under the network, GlycoNet Integrated Services (GIS) operates as a national platform of glycomics services. GlycoNet and GIS together provide one-stop access to glycomics tools, specialized expertise, consulting and collaborative opportunities to academia and industry, both nationally and internationally. GlycoNet is also a leader in training the next generation of glyco-scientists and promoting collaboration and advancement in glycomics research. GlycoNet is supported in part through the Government of Canada’s Strategic Science Fund, the Canada Foundation for Innovation’s Major Science Initiatives Fund, Genome Canada’s Technology Development Program and Alberta Innovates. Learn more: glyconet.ca

About CIC bioGUNE
The Centre for Cooperative Research in Biosciences (CIC bioGUNE), member of the Basque Research & Technology Alliance (BRTA), located in the Bizkaia Technology Park, is a biomedical research organisation conducting cutting-edge research at the interface between structural, molecular and cell biology, with a particular focus on generating knowledge on the molecular bases of disease, for use in the development of new diagnostic methods and advanced therapies.

Media Contacts: 

GlycoNet:
Aalyssa Atley
Director of Communications
GlycoNet
aatley@glyconet.ca

CIC bioGUNE:
Jana Sendra
Communications Manager
CIC bioGUNE
jsendra@cicbiogune.es

Original source here.